GENE
Genetic Technologies Ltd.
GENE
GENE
Delisted
GENE was delisted on the 16th of October, 2024.
10 hedge funds and large institutions have $69.1K invested in Genetic Technologies Ltd. in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
2
Calls
$30K
Puts
–
Net Calls
+$30K
Net Calls Change
+$30K
Top Buyers
1 |
TSS
1
Two Sigma Securities
New York
|
$11.2K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$6.87K |
3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$11.7K |
4 |
4
Morgan Stanley
New York
|
$15K |
5 |
5
Citadel Advisors
Miami,
Florida
|
$510 |
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$0 |
2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$20.7K |